Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies
出版年份 2013 全文链接
标题
Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies
作者
关键词
-
出版物
ONCOGENE
Volume 33, Issue 5, Pages 619-631
出版商
Springer Nature
发表日期
2013-01-21
DOI
10.1038/onc.2012.625
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31
- (2011) Edith A. Perez et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial
- (2011) Luca Gianni et al. LANCET ONCOLOGY
- Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+breast cancer patients
- (2011) Maurizio Scaltriti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Functional Viability Profiles of Breast Cancer
- (2011) R. Brough et al. Cancer Discovery
- Genome profiling of ERBB2-amplified breast cancers
- (2010) Fabrice Sircoulomb et al. BMC CANCER
- ROCK: a breast cancer functional genomics resource
- (2010) David Sims et al. BREAST CANCER RESEARCH AND TREATMENT
- DNA amplifications in breast cancer: genotypic–phenotypic correlations
- (2010) Kai-Keen Shiu et al. Future Oncology
- Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells
- (2010) George W. Woodfield et al. GENES CHROMOSOMES & CANCER
- Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Therapy
- (2010) José Baselga et al. JOURNAL OF CLINICAL ONCOLOGY
- Loss of Phosphatase and Tensin Homolog or Phosphoinositol-3 Kinase Activation and Response to Trastuzumab or Lapatinib in Human Epidermal Growth Factor Receptor 2–Overexpressing Locally Advanced Breast Cancers
- (2010) Bhuvanesh Dave et al. JOURNAL OF CLINICAL ONCOLOGY
- Activated Phosphoinositide 3-Kinase/AKT Signaling Confers Resistance to Trastuzumab but not Lapatinib
- (2010) N. A. O'Brien et al. MOLECULAR CANCER THERAPEUTICS
- Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
- (2010) N Turner et al. ONCOGENE
- Identification of target genes of transcription factor activator protein 2 gamma in breast cancer cells
- (2009) He Ailan et al. BMC CANCER
- A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell lines
- (2009) Alan Mackay et al. BREAST CANCER RESEARCH AND TREATMENT
- An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers
- (2009) Rachael Natrajan et al. BREAST CANCER RESEARCH AND TREATMENT
- Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines
- (2009) Antoinette Hollestelle et al. BREAST CANCER RESEARCH AND TREATMENT
- Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers
- (2009) R. Natrajan et al. CLINICAL CANCER RESEARCH
- AP-2γ promotes proliferation in breast tumour cells by direct repression of the CDKN1A gene
- (2009) Christopher M J Williams et al. EMBO JOURNAL
- Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor-PI3K Axis
- (2009) B. Schoeberl et al. Science Signaling
- A Central Role for HER3 in HER2-Amplified Breast Cancer: Implications for Targeted Therapy
- (2008) S. T. Lee-Hoeflich et al. CANCER RESEARCH
- Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235
- (2008) P. J.A. Eichhorn et al. CANCER RESEARCH
- Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia—A comparative study of four differently designed, high resolution microarray platforms
- (2008) Rebeqa Gunnarsson et al. GENES CHROMOSOMES & CANCER
- The genomic profile ofHER2-amplified breast cancers: the influence of ER status
- (2008) C Marchiò et al. JOURNAL OF PATHOLOGY
- Overexpression ofTFAP2Cin invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival
- (2008) JMW Gee et al. JOURNAL OF PATHOLOGY
- Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines
- (2008) Edurne Arriola et al. LABORATORY INVESTIGATION
- Comparative Genomic Hybridisation Arrays: High-Throughput Tools to Determine Targeted Therapy in Breast Cancer
- (2008) David S.P. Tan et al. PATHOBIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started